Interestingly, GPER1 has been suggested as a target of interest for neurological disorders, and in recent transcriptomic studies, reduced GPER1 expression has been observed in the blood and brains of Mecp2 null mice, opening the possibility that Mecp2 acts as a transcriptional regulator of this receptor [108,109]. This evidence concerns the gene GPER1 and nervous system disorder.